Research
Leverage Berkadia’s CRE market research to help inform your investment strategy. Our Annual Forecast, quarterly and specialty reports will provide you with valuable data-driven insights.
To print a report, please download the Apartment Update® PDFs to your desktop and print using Adobe Acrobat.
Search for Research
From the Newsroom
March 31, 2026
Seven‑Property Multifamily Portfolio, Chicago, IL | Sold by Berkadia 2026
Aimco Sells $455M Seven-Property, 1495-unit Chicago Multifamily Portfolio to Laterra Capital Management & Respark Residential Chicago, Illinois – March 31, 2026 – Berkadia, distinguished leader in the commercial real estate sector, announced today the sale of a seven‑property multifamily portfolio in Chicago, Illinois. Senior Managing Director Pete Evans of the Chicago office and Senior Director Richard Evans of the Milwaukee office advised the seller,…
March 31, 2026
Silverview RV Resort, Bullhead City, AZ | Sold and Financed by Berkadia 2026
Berkadia Completes Sale and Secures $8.8 Million in Financing for Manufactured Housing Community in Arizona Bullhead City, Arizona – March 31, 2026 – Berkadia Manufactured Housing announced today the sale and financing of Silverview RV Resort, a 423-site RV resort in Bullhead City, Arizona. Director Hunter LaRocca along with Senior Managing Director Kevan Enger, Managing Director Ian Hilpl, and Director Brian Hummell of Berkadia’s Manufactured Housing Investment Sales team led the sale on behalf of…
March 27, 2026
Greenhouse Medical Plaza, Houston, TX | Sold and Financed by Berkadia 2026
Berkadia Announces the Sale and Financing of a Value-Add Medical Outpatient Building in Houston, Texas HOUSTON, TEXAS – March 27, 2026 – Berkadia, a distinguished leader in the commercial real estate sector, announced today the sale and financing of Greenhouse Medical Plaza, a 116,869-square foot, institutional-quality outpatient medical building located in Houston, Texas. Managing Director Vasili Davos, Senior Managing Director Sabrina Solomiany, and Managing Directors Chris Lashmet and Eric Lee of Berkadia Medical & Life Sciences led the transaction on behalf…